新生儿筛查短链酰基辅酶A脱氢酶缺乏症的临床、生化与基因突变特征
该研究回顾性分析2009年1月至2015年10月浙江新生儿筛查确诊的17例短链酰基辅酶A脱氢酶缺乏症(SCADD)患儿,发病率1/84117,所有患儿无临床症状且生长发育正常,血丁酰基肉碱(C4)及比值升高,尿乙基丙二酸升高,ACADS基因常见突变为c.1031A>G、c.164C>T和c.991G>A。
要点
- 新生儿筛查确诊的SCADD患儿均无临床症状,智力与体格发育正常。
- 血C4及C4/C2、C4/C3比值升高,尿乙基丙二酸升高是主要生化特征。
- ACADS基因常见突变包括c.1031A>G、c.164C>T和c.991G>A。
核心结论
- SCADD新生儿筛查病例无临床症状,发病率1/84117,c.164C>T和c.1031A>G可能为常见突变。
研究设计与样本
- 回顾性分析2009年1月至2015年10月浙江大学医学院附属儿童医院遗传代谢科(浙江省新生儿筛查中心)经串联质谱新生儿筛查确诊的SCADD患儿的尿有机酸和ACADS基因突变特征。
主要发现
- 共筛查1 430 024名新生儿,确诊17例SCADD,发病率1/84117。
- 所有患儿无临床症状,智力和体格发育正常。
- 血C4水平为0.713.14 μmol/L(参考值0.03-0.48 μmol/L),C4/C2为0.07-0.23(参考值0.01-0.04),C4/C3为0.65-2.04(参考值0.05-0.39)。
- 13例尿乙基丙二酸升高(9.30-90.99 mg/g肌酐,参考值0-6.20 mg/g肌酐),1例伴甲基琥珀酸升高(12.33 mg/g肌酐,参考值0-6.40 mg/g肌酐),1例伴乙酰甘氨酸升高(3.52 mg/g肌酐,参考值0-0.70 mg/g肌酐)。
- ACADS基因检出13种已知突变,1种纯合突变(c.1031A>G),其余为复合杂合突变;检出1种移码突变(c.508_509delGC)和12种错义突变;常见突变为c.1031A>G(35.3%)、c.164C>T(20.6%)和c.991G>A(11.8%)。
关键数值与推荐
- 血C4参考值0.03-0.48 μmol/L,C4/C2参考值0.01-0.04,C4/C3参考值0.05-0.39。
- 尿乙基丙二酸参考值0-6.20 mg/g肌酐,甲基琥珀酸参考值0-6.40 mg/g肌酐,乙酰甘氨酸参考值0-0.70 mg/g肌酐。
- ACADS基因常见突变频率:c.1031A>G 35.3%,c.164C>T 20.6%,c.991G>A 11.8%。
临床怎么用
- 对新生儿筛查C4及比值升高者应进行尿有机酸和ACADS基因分析以确诊SCADD。
- 确诊SCADD患儿可给予饮食指导、生活管理和L-肉碱补充,并随访生长发育和智力发育。
局限性
- 随访时间较短(8-42个月),样本量较小(17例),为单中心回顾性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the incidence, clinical, biochemical and gene mutation characteristics of short chain acyl-coenzyme A dehydrogenase deficiency (SCADD). Method: From January, 2009 to October, 2015, a retrospective analysis of the urine organic acids and acyl-coenzyme A dehydrogenase (ACADS) gene mutation characteristics of patients diagnosed as SCADD by newborn screening using tandem mass spectrometry in Department of Genetics and Metabolism (Newborn screening Center of Zhejiang Province), Children's Hospital, Zhejiang University School of Medicine. Dietary guidance, life management and supplementation of L-carnitine were conducted, and growth and intelligence development were observed during follow-up among the SCADD patients. Result: A total of 1 430 024 neonates, seventeen cases were diagnosed with SCADD with an incidence of 1/84 117. All patients had no clinical symptoms, and intelligence and physical development were normal. Blood butylacyl-carnitine (C4) levels and the ratios increased, C4 0.713.14 μmol/L(reference value 0.03-0.48 μmol/L), C4/C2 0.07-0.23(reference value 0.01-0.04), C4/C3 0.65-2.04(reference value 0.05-0.39). Thirteen with increased urinary ethyl malonic acid (9.30-90.99 mg/g creatinine (reference value 0-6.20 mg/g creatinine )), one patient was accompanied by increased methyl succinic acid (12.33 mg/g creatinine(reference value 0-6.40 mg/g creatinine)), one subject with increased acetylglycine (3.52 mg/g creatinine(reference value 0-0.70 mg/g creatinine)). A total of 13 known mutations were detected in the ACADS gene, 1 homozygous mutation (c.1031A>G), the others are compound heterozygous mutations. One frameshift mutation (c.508_509delGC) and 12 missense mutations were detected. Common mutation were c. 1031A>G(35.3%), c. 164C>T(20.6%) and c. 991G>A(11.8%). SCADD in newborn screening program had no clinical symptoms and normal growth development after 8-42 months follow-up. Conclusion: Cases with SCADD had no clinical symptoms with an incidence of 1/84117. The c. 164C>T and c. 1031A>G may be the common mutations.
引用
- Huang XW, Zhang Y, Yang JB, et al. [Clinical, biochemical and gene mutation characteristics of short chain acyl-coenzyme A dehydrogenase deficiency by neonatal screening]. Zhonghua Er Ke Za Zhi. 2016. PMID: 27938594. doi:10.3760/cma.j.issn.0578-1310.2016.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。